ArticleVaccines2024

Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma.

Panagiotis T Diamantopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.